Dylan Ferreira

Fernando Pessoa University — Portugal

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index727citations38works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glycosylation and Glycoproteins Research(21), Galectins and Cancer Biology(6), Bladder and Urothelial Cancer Treatments(5), RNA modifications and cancer(5), Cancer Research and Treatments(5)

Publications38 total

P1.17.21 Gender Disparities in Remote Patient Monitoring: Analysis From 973 Lung Cancer Patients Treated Across 42 Sites in France and Belgium
Journal of Thoracic Oncology·2025
Trimmed <i>N</i>-glycans define aggressive gastric cancer and predict clinical outcomes
Theranostics·2025Open Access
CD276 Immature Glycosylation Drives Colorectal Cancer Aggressiveness and T-cell Mediated Immune Escape
2025Open Access
Molecular characterisation of Mozambican patients diagnosed with colorectal adenocarcinoma
Journal of Gastrointestinal Oncology·2025Open Access
Glycomics and Glycoproteomics Reveal Distinct Oligomannose Carriers Across Bladder Cancer Stages
International Journal of Molecular Sciences·2025· 2 citedOpen Access
Coding and regulatory somatic profiling of triple-negative breast cancer in Sub-Saharan African patients
Scientific Reports·2025· 1 citedOpen Access
Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic and glucose-deprived bladder cancer cells
iScience·2025· 7 citedOpen Access
E‐selectin affinity glycoproteomics reveals neuroendocrine proteins and the secretin receptor as a poor‐prognosis signature in colorectal cancer
Molecular Oncology·2024· 3 citedOpen Access
Author response for "E‐selectin affinity glycoproteomics reveals neuroendocrine proteins and the secretin receptor as a poor‐prognosis signature in colorectal cancer"
2024
Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer
International Journal of Molecular Sciences·2024· 7 citedOpen Access
Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy
ACS Nano·2024· 12 cited
Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer
International Journal of Molecular Sciences·2024· 3 citedOpen Access
A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy
Journal of Controlled Release·2024· 12 cited
Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells
2023· 3 citedOpen Access
XPERT® breast cancer STRAT4 as an alternative method of identifying breast cancer phenotype in Cape Verde (preliminary results)
ecancermedicalscience·2023· 4 citedOpen Access
Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients
Cells·2022· 20 citedOpen Access
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
Theranostics·2022· 41 citedOpen Access
Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion
2021· 1 citedOpen Access
Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
Journal of Experimental & Clinical Cancer Research·2021· 37 citedOpen Access
Target Score—A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness
International Journal of Molecular Sciences·2021· 18 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Lúcio Lara Santos(33), José Alexandre Ferreira(27), Marta Relvas‐Santos(20), Andreia Peixoto(19), André M. N. Silva(18), Sofia Cotton(16), Luís Lima(16), Janine Soares(16), Carlos Palmeira(14), Rita Azevedo(13), Cristiana Gaiteiro(13), Rui Freitas(13), Elisabete Fernandes(12), Luís Pedro Afonso(10), María José Oliveira(9), Andreia Brandão(9), Eduardo Ferreira(9), Andréia Miranda(8), Beatriz Santos(8), Paula Paulo(7)